1. Home
  2. VET vs BCRX Comparison

VET vs BCRX Comparison

Compare VET & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vermilion Energy Inc.

VET

Vermilion Energy Inc.

HOLD

Current Price

$11.30

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.47

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VET
BCRX
Founded
1994
1986
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
VET
BCRX
Price
$11.30
$8.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$15.00
$20.82
AVG Volume (30 Days)
1.9M
4.0M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
3.29%
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
$10.98
N/A
Revenue Next Year
N/A
$12.55
P/E Ratio
N/A
$7.00
Revenue Growth
N/A
N/A
52 Week Low
$5.14
$6.00
52 Week High
$12.00
$11.31

Technical Indicators

Market Signals
Indicator
VET
BCRX
Relative Strength Index (RSI) 67.32 69.72
Support Level $7.18 $7.95
Resistance Level N/A $8.68
Average True Range (ATR) 0.48 0.33
MACD 0.04 0.12
Stochastic Oscillator 70.09 81.19

Price Performance

Historical Comparison
VET
BCRX

About VET Vermilion Energy Inc.

Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: